Human Chronic Lymphoid Leukemia Peripheral Blood CD19+/CD5+ B Cells (Relapsed/Refractory)

Blood and Immune Cells & Products > Peripheral Blood Cells

Product Type: Immune Cells

Species: Human

Cell Type: Immune Cells

Source Organ: Blood

$1,249.00

Size

1 vial

Care information

Display general product information or specific product information using metafields.

Add some general information about your delivery and shipping policies.

Cell Name: Human Chronic Lymphoid Leukemia Peripheral Blood CD19+/CD5+ B Cells (Relapsed/Refractory)

Description

Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia peripheral blood mononuclear cells using a direct immunomagnetic CD19+ MicroBead labeling system. Available in untreated or relapsed/refractory stages.
The co-expression of CD5 is typically found on cancerous Chronic Lymphoid LeukemiaCD19+ B cells. Current research is underway to identify the Chronic Lymphoid Leukemia clonal origin of Chronic Lymphoid Leukemia from this cell population. Although these cells appear mature in morphology, they are in developmental arrest. Researchers have shown that only 1% of these cells are in an active cycle. CD19+/CD5+ B cells play an important role in production of IgM autoantibodies.
Product Name

Human Chronic Lymphoid Leukemia Peripheral Blood CD19+/CD5+ B Cells (Relapsed/Refractory)
Product Type

Immune Cells
Species

Human
Cell Type

B Cell
Source Organ

Peripheral Blood
Disease

Chronic Lymphoid Leukemia
Product Type

Immune Cells
Growth Conditions

37 °C, 5% CO2
Size/Quantity

1 vial
Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.
Shipping Conditions

Dry Ice
Storage

Liquid Nitrogen
Biosafety Level

1

Payment methods

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.